Tumour necrosis factor-a induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis S. Kondo (Lanier et al., 1986; Biassori et al., 1988; Loh et al., 1988) .
Numerous studies have shown that target cells which express a relatively low level of HLA class I antigen have increased susceptibility to lysis by NK cells, while target cells with a relatively high level of HLA class I antigen are less susceptible Piontek et al., 1985; Harel-Bellan et al., 1986; Storkus et al., 1987) . On the other hand, the results of some studies suggest that the extent of NK cell-mediated lysis is correlated with the level of HLA class I antigen expression only within certain ranges of expression (Storkus et al., 1989) , and may be influenced by adhesion molecules such as intercellular adhesion molecule I (ICAM-1), which play roles in the interaction between target cells and effector cells (Maio et al., 1991) . However, the mechanism of NK-cell lysis remains controversial.
Tumour necrosis factor (TNF)-a, a polypeptide cytokine with a molecular weight of about 17,500 produced primarily by macrophages, plays a role in immune defence against a variety of pathogenic agents by virtue of its possession of a variety of effects on cell function (Beutler & Cerami, 1987; Old, 1987) . Some of these effects may result in cell death and tissue damage. TNF-a is directly cytocidal to certain cells and can also enhance indirect cell killing by stimulation of other immune functions that are themselves cytocidal (Konig et al., 1991) . In addition, TNF-a significantly enhances the expression of ICAM-1 and HLA class I antigen on treated cells (Kuppner et al., 1990; Maio *et al., 1991) . A recent study demonstrated that TNF-ox-treated target cells are significantly less susceptible to NK cell-mediated lysis than their untreated counterparts (Maio et al., 1991) . In contrast, in other studies no effect of TNF-a on target cell susceptibility to NK cells has been detected (Tomita et al., 1992) .
In this study we tested the effect of TNF- were quantified using a modified 3-(4,5-diemthylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT, Chemicon, Temecula, CA, USA) colorimetric assay (Mosmann, 1983) . Target cells were seeded at I04 cells per well (0.1 ml) in 96-well flat-bottomed plates (Corning, NY, USA) and incubated overnight at 37°C. TNF-m was then added (0.01 ml per well) at concentrations ranging between 1 and 100unitsml-'. After a 48h period of incubation at 37°C, 0.01 ml of MTT reagent was added to each well. After another 4 h period of incubation at 37°C, 0.1 ml of isopropanol with 0.04 M hydrochloric acid was added to each well to dissolve precipitates, and absorbance was then measured at 570 nm with an autoreader (ER-8000, Sanko Junyaku, Tokyo, Japan) within 30 min of dissolution.
ICAM-J antisense oligonucleotide synthesis and cellular uptake A 20-mer antisense (antisense ICAM-1) oligonucleotide (5'-dGGACACAGATGTCTGGGCAT-3') complementary to a sequence beginning at position 77 downstream of the ATG initiation codon of ICAM-1 cDNA (Simmons et al., 1988) was synthesised using methods described previously (Akella & Hall, 1992) . Oligonucleotide uptake was assayed using methods already described (Wickstrom et al., 1988) . For each time point, 5 x I04 c.p.m. of 32P-labelled oligonucleotide was added to 106 U87-MG cells in 0.5 ml of culture medium. After incubation at 37°C, the cells were harvested, washed and lysed, and percentage uptake was then determined. Figure 1 , we found that treating U87-MG cells with Acid treatment The acid solution used was 0.2 M citric acid-disodium hydrogen phosphate buffer, pH 3.0, containing 1% (w/v) bovine serum albumin prepared as previously described (Sugawara et al., 1989) . Cell pellets containing 2 x 106 U87-MG cells were placed in 0.5 ml of the buffered solution at 4°C for 2 min. Cells were then immediately neutralised with excess medium, washed three times and used as target cells. It has been shown that HLA class I antigen expression is selectively eliminated by this treatment, while the expression of other antigens, such as HLA class II, CD3, CD4 and CD8 antigens, transferrin receptors (Sugawara et al., 1989) E/T ratios of 20 and 40 (P <0.05). In addition, the combined treatment with TNF-a and antisense ICAM-1 decreased susceptibility to NK lysis of U87-MG cells compared with antisense ICAM-1 treatment alone (P<0.1). On the other hand, TNF-a-treated U87-MG cells had greatly increased susceptibility to lysis by NK cells after acid treatment at all E/T ratios tested (P<0.05). Moreover, the combined treatment with TNF-a and acid increased susceptibility to NK lysis of U87-MG cells compared with acid treatment alone (P<0.05). These results suggest the possibility that the increased NK susceptibility of TNF-x-treated U87-MG cells mostly depends on the increased expression of ICAM-1 on target cells, whereas HLA class I antigen expression has a protective effect. Similar results were obtained with GI-1 cells (derived from human malignant glioma cells, Miyatake et al., 1990; Kondo et al., 1992) .
Discussion
It has been proposed that HLA antigens are regulators of tumour cell susceptibility to immune cytolysis, and lack of HLA class I antigen has generally been found to be associated with increased susceptibility to lysis by NK cells (Tanaka et al., 1986; Weber et al., 1987; Ljunggren & Karre, 1990 ). However, in some studies no significant change has been detected in the extent of NK-cell-mediated lysis when HLA class I antigen expression is below a threshold level or above a plateau level (Storkus et al., 1989) . On the other hand, it has been found that some adhesion factors, such as ICAM-1, and extracellular matrix proteins such as laminin, collagen IV and fibronectin can activate cytolytic immunity effectors through the lymphocyte function-associated antigen (LFA) and very late antigen (VLA) receptor system (Young, 1989; Takahashi et al., 1990; Santoni et al., 1991) . Furthermore, several non-specific properties of tumour cells have been implicated in the susceptibility of such cells to lysis by NK cells. Cell-surface hydrophobicity (Becker et al., 1979) , sialic acid composition (Yogeeswaran et al., 1981) , glycoprotein composition (Young et al., 1981) , cell membrane repair mechanisms (Kunkel & Welsh, 1981) and cell membrane potential (Stevenson et al., 1989) TNF-o (Kuppner et al., 1990; Miyatake et al., 1990) . The non-HLA-NK cytolysis-related structures are also more susceptible to modulation by TNF-a than by IFN-'y (Maio et al., 1991 (Maio et al., 1991) . The ability of a MAb to detect antigenic determinants may be somewhat decreased with the use of F(ab')2 fragments prepared by-pepsin digestion: the MAb is capable of blocking cell-mediated cytotoxicity but does not eliminate ICAM-1 from the cell surface, and there may also be differences in characteristics of the MAb tested and in the antigenic profiles of the cells. Acid treatment resulted in the elimination of HLA class I antigen expression, but did not affect the expression of ICAM-1, NCAM, HLA class II or other similar cell-surface antigens, confirming the findings of Sugawara et al. (1989) . However, there has been no report demonstrating whether non-specific properties such as cell membrane potential remain unchanged after acid treatment. We suggest that acid treatment has no effect on these non-specific properties since K562 cells expressing no or very low HLA class I antigen showed the same susceptibility to NK lysis before and after acid treatment (Sugawara et al., 1989) . We also showed that antisense ICAM-1 induced significant inhibition of NK-cell-mediated lysis of TNF-a-treated U87-MG cells. Acid treatment following TNF-a treatment also greatly increased lysis by NK cells. These findings indicate that TNF-o treatment of glioblastoma cells increased their susceptibility to lysis by NK cells, since ICAM-1 upregulation would have more profound effects on NK susceptibility than would HLA class I antigen up-regulation.
Treatments with TNF-a or IFN-y have in a variety of studies increased, decreased or left unchanged the susceptibility of tumour cells to lysis by NK/lymphokine-activated killer (LAK) cells (Miyatake et al., 1990; Maio et al., 1991; Akella & Hall, 1992; Fady et al., 1992; Kondo et al., 1992) .
One possible explanation for the inconsistencies among these findings would be the existence of differences not only in the levels of ICAM-1 and HLA class I antigen but also in the susceptibility to lysis by NK/LAK cells of cells not treated with cytokines (Fady et al., 1992) . A NK/LAK-resistant target cell with a high level of expression of HLA class I antigen but a low level of expression of ICAM-1 would be more likely to respond to cytokines with enhanced susceptibility to lysis.
Moreover, since TNF-x plays a role in immune defence against a variety of pathogenic agents by virtue of its possession of a variety of effects on cell function (Beutler & Cerami, 1987; Old, 1987; Konig et al., 1991) , it is possible that an unknown molecule, neither ICAM-1 nor HLA class I antigen, might be responsible for susceptibility to lysis by NK cells. Several groups have shown that marked inhibition of NK-mediated cytolysis is induced by anti-LFA-1-e (CDlla) and anti-LFA-l-,B (CD18) MAbs; these findings strongly suggest such surface molecules play important roles in NK-mediated cytolysis (Hall et al., 1985; Schmidt et al., 1985) . In addition, it has been found that ICAM-1 appears to be constitutively avid for LFA-1. In contrast, cell-surface LFA-1 is not constitutively avid for ICAM-1 (Dustin & Springer, 1988) . The findings of these studies suggest that LFA-1 ligands other than ICAM-1 may be present on NK targets. Another possible explanation is that the intrinsic ability of the target cells to be lysed might be altered by TNF-a. However, further studies are needed to determine clearly the mechanism of NK-mediated lysis.
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